Does SITAGLIPTIN Cause Hypoglycaemic encephalopathy? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hypoglycaemic encephalopathy have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.1% of all adverse event reports for SITAGLIPTIN.
19
Reports of Hypoglycaemic encephalopathy with SITAGLIPTIN
0.1%
of all SITAGLIPTIN reports
7
Deaths
19
Hospitalizations
How Dangerous Is Hypoglycaemic encephalopathy From SITAGLIPTIN?
Of the 19 reports, 7 (36.8%) resulted in death, 19 (100.0%) required hospitalization, and 3 (15.8%) were considered life-threatening.
Is Hypoglycaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Hypoglycaemic encephalopathy?
METFORMIN (59)
GLIMEPIRIDE (49)
INSULIN GLARGINE (33)
INSULIN DEGLUDEC (24)
INSULIN ASPART (23)
INSULIN HUMAN (15)
GLYBURIDE (13)
INSULIN ASPART\INSULIN DEGLUDEC (12)
REPAGLINIDE (12)
INSULIN LISPRO (9)
Which SITAGLIPTIN Alternatives Have Lower Hypoglycaemic encephalopathy Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE